Cargando…
Opportunities for research in molecular radiotherapy
Cancer has been treated with radiopharmaceuticals for 80 years. A recent National Cancer Research Institute report from the Clinical and Translational Radiotherapy Research Working Group reviews the current status of molecular radiotherapy and has highlighted the barriers to and opportunities for in...
Autores principales: | Flux, Glenn D, O'Sullivan, Joe, Gaze, Mark N, Prise, Kevin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601516/ https://www.ncbi.nlm.nih.gov/pubmed/28055251 http://dx.doi.org/10.1259/bjr.20160921 |
Ejemplares similares
-
Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy
por: Denis-Bacelar, Ana M, et al.
Publicado: (2018) -
BNMS position statement on molecular radiotherapy
por: Flux, Glenn, et al.
Publicado: (2021) -
A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases
por: Denis-Bacelar, Ana M, et al.
Publicado: (2017) -
What is the Role of the Bystander Response in Radionuclide Therapies?
por: Brady, Darren, et al.
Publicado: (2013) -
Delivering a research‐enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
por: Lawler, Mark, et al.
Publicado: (2015)